| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1180.8B | ¥1138.4B | +3.7% |
| Operating Income | ¥83.3B | ¥31.1B | +168.2% |
| Ordinary Income | ¥92.2B | ¥41.2B | +124.0% |
| Net Income | ¥68.8B | ¥11.6B | +490.6% |
| ROE | 14.1% | 2.4% | - |
FY2026 Q3 results showed robust profitability recovery with revenue of 118.1B yen (YoY +3.7%), operating income of 8.3B yen (YoY +168.2%), ordinary income of 9.2B yen (YoY +124.0%), and net income of 6.9B yen (up from 1.2B yen prior year). Operating margin expanded significantly to 7.1% from 2.7% in the prior year, driven by gross margin improvement of 260 basis points to 14.3% and substantial reduction in product warranty expenses. Net profit margin reached 5.8%, up 480 basis points from 1.0% prior year. The company demonstrated strong cash generation with operating cash flow of 10.9B yen exceeding net income by 1.58 times, while free cash flow of 5.5B yen fully covered shareholder returns including 3.6B yen in share buybacks and dividends totaling 1.9B yen.
[Profitability] ROE of 14.1% represents substantial improvement, decomposed as net profit margin 5.8% (up from 1.0% prior year) multiplied by asset turnover 1.216 (up from 1.168) and financial leverage 1.99 times. Operating margin expanded 433 basis points to 7.1% from 2.7%, driven by gross margin improvement to 14.3% from 11.7% and selling, general and administrative expense optimization particularly through reduction in product warranty provisions from 15.8B yen to 2.0B yen. ROA reached 7.1%, reflecting both margin expansion and modest asset efficiency gains. [Cash Quality] Cash and deposits stood at 83.7B yen, providing 12.15 times coverage of short-term debt which declined significantly to 6.9B yen from 60.4B yen prior year. Operating cash flow conversion ratio of 1.58 times net income confirms cash-backed earnings quality. [Investment Efficiency] Asset turnover of 1.216 improved from 1.168, with receivables turnover days at 74 days exceeding optimal levels, inventory turnover days at 158 days, and payables turnover days at 204 days. Property, plant and equipment represents 30.5% of total assets with construction in progress at 16.5%, indicating ongoing capacity and efficiency enhancement investments. CapEx to depreciation ratio of 1.30 times demonstrates balanced growth and renewal investment. [Financial Health] Equity ratio of 50.3% provides stable capital foundation. Current ratio of 205.3% and quick ratio of 192.6% indicate strong liquidity positioning. Debt-to-equity ratio of 0.99 times and debt-to-capital ratio of 25.4% reflect conservative leverage. Interest coverage measured by EBITDA stands at 46.8 times, with debt-to-EBITDA of 1.35 times demonstrating solid debt servicing capacity. Short-term debt ratio of 7.1% minimizes refinancing risk.
Operating cash flow of 10.9B yen represents 1.58 times net income of 6.9B yen, confirming cash-backed earnings quality. Working capital dynamics showed significant impact from accounts payable increase of 29.4B yen which positively contributed to operating cash flow, while accounts receivable increase of 5.6B yen and inventory accumulation of 5.8B yen created drags on cash generation. Reduction in product warranty provisions by 5.1B yen represented a headwind to operating cash flow. Investing cash flow of 5.4B yen was primarily driven by capital expenditures of 5.2B yen for production capacity and efficiency enhancements. Financing cash flow included share buybacks of 3.6B yen and dividend payments of 1.9B yen, totaling 5.5B yen in shareholder returns. Free cash flow of 5.5B yen fully covered total shareholder distributions, demonstrating sustainable capital allocation. Interest payments of 0.2B yen represent minimal burden on cash flow generation. Cash position evolution reflects business operating leverage improvement and deliberate debt structure optimization toward longer-term maturities.
Ordinary income of 9.2B yen versus operating income of 8.3B yen indicates net non-operating contribution of approximately 0.9B yen, primarily comprising equity method investment gains of 0.5B yen and reduced financial expenses. Non-operating income represents 0.8% of revenue, with interest and dividend income combined with modest foreign exchange gains of 0.05B yen. Special gains from investment securities sales of 0.5B yen contributed approximately 7% to pre-tax income but represent non-recurring items. The substantial operating income growth of 5.2B yen year-over-year stems primarily from gross profit improvement of 3.0B yen and SGA expense reduction of 2.2B yen, with the latter heavily influenced by product warranty provision normalization declining 13.7B yen from prior year extraordinary levels. Operating cash flow exceeding net income by 58% confirms healthy earnings quality on a cash basis. The warranty provision reduction represents normalization from elevated prior-year levels rather than ongoing operational improvement, suggesting approximately 5B yen of the operating income expansion reflects one-time benefit reversal. Adjusted for this factor, underlying operational improvement still contributed approximately 3B yen or 60% of the reported operating income expansion, indicating sustainable core business strengthening.
Gross margin of 14.3% remains below typical industry thresholds of 20%, exposing the company to raw material cost volatility and limited pricing power, particularly in cyclical automotive market conditions where cost pass-through may lag. Days sales outstanding of 74 days exceeds the 60-day benchmark, indicating extended collection periods with potential credit risk concentration and working capital inefficiency that could impair cash conversion if customer payment discipline deteriorates. Heavy reliance on accounts payable extension with days payable outstanding reaching 204 days creates structural working capital dependency on supplier credit terms, which could reverse rapidly under supply chain stress or supplier financial distress, potentially requiring 29B yen in cash outflow to normalize payment terms. Manufacturing capacity expansion evidenced by 16.1B yen in construction in progress carries execution risk regarding timeline, cost overruns, and utilization ramp-up that may delay anticipated efficiency gains and return on invested capital.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates mixed positioning within the manufacturing sector peer group. Profitability metrics show competitive strength with ROE of 14.1% substantially exceeding the industry median of 5.0% and operating margin of 7.1% below but approaching the industry median of 8.3%. Net profit margin of 5.8% aligns closely with the industry median of 6.3%, indicating typical conversion efficiency at the bottom line. Financial health metrics reflect moderate leverage with equity ratio of 50.3% below the industry median of 63.8%, though current ratio of 205.3% significantly below the industry median of 284.0% suggests tighter working capital management. Efficiency metrics reveal superior asset productivity with asset turnover of 1.216 substantially exceeding the industry median of 0.58, offsetting margin constraints through volume throughput. Revenue growth of 3.7% outpaces the industry median of 2.7%, demonstrating market share gains or end-market strength. Working capital management shows areas for improvement with days sales outstanding of 74 days below the industry median of 83 days but still elevated, and days inventory outstanding of 158 days above the industry median of 109 days, though extended days payable outstanding of 204 days far exceeds the industry median of 56 days, creating favorable cash conversion cycle positioning. Cash conversion ratio of 1.58 exceeds the industry median of 1.24, indicating superior earnings quality. The company's CapEx to depreciation ratio of 1.30 sits below the industry median of 1.44, suggesting measured investment intensity. Overall positioning reflects a higher-turnover, moderate-margin manufacturing business with strong cash generation capability and room for margin expansion toward industry norms.
※ Industry: Manufacturing sector (98 companies for most metrics), Comparison: FY2025 Q3 cross-sectional benchmarks, Source: Proprietary analysis
The substantial operating margin expansion of 433 basis points to 7.1% reflects both structural improvements in gross margin through cost reduction and production efficiency as well as one-time benefit from warranty provision normalization, with approximately 60% of the operating income growth attributable to sustainable operational factors and 40% representing reversal of prior-year extraordinary charges, establishing a new baseline profitability level between historical trough and current peak. Working capital management presents significant opportunity as evidenced by days sales outstanding of 74 days and inventory days of 158 days, where collection acceleration and inventory optimization could unlock approximately 15-20B yen in additional cash generation equivalent to 150-200% of current annual free cash flow, representing the most tangible near-term value creation lever. The company has executed meaningful balance sheet optimization through reduction of short-term debt by 80.5% to 1.2B yen while extending debt maturity profile, simultaneously returning 5.5B yen to shareholders while maintaining free cash flow neutrality, demonstrating disciplined capital allocation with sustainable payout capacity supporting the announced annual dividend of 160 yen per share representing a conservative 20.6% payout ratio with significant upside flexibility if operational improvements continue.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.